Pfizer: 3rd dose may be needed for younger kids
[anvplayer video=”5078842″ station=”998132″]
Pfizer and BioNTech are now testing a third dose of their COVID-19 vaccine in kids between the ages of 6 months and 5 years.
They say two doses did not generate a strong enough immune response in some kids in the study.
This trial is ongoing and there is no final word yet.
